HOME >> BIOLOGY >> NEWS
Small RNA surmounts large cancer problem

Many potentially effective cancer treatments are undone by the onset of resistance to the treatment. In order to circumvent this problem, D. Gary Gilliland and colleagues, of Brigham and Women's Hospital, have developed a strategy using the latest technologies involving small interfering RNA to enhance cancer treatment even in a situation where drug resistance has developed. Small interfering RNAs work by inhibiting the expression of specific genes that have a matching complimentary sequence. The authors theorized that this type of RNA treatment might boost the effectiveness of anti-cancer treatments. They tested their theory in a form of leukemia that is caused when two genes fuse to form an unregulated gene that transforms normal cells into cancer cells, a gene called TEL-PDGFbetaR. This form of leukemia is generally treated with a commonly used anti-cancer drug called imatinib, which is a small molecule protein inhibitor that blocks the activity of the protein produced from the fusion gene TEL-PDGFbetaR. Gilliland and colleagues created a small inhibitory RNA specific to the TEL-PDGFbetaR fusion gene, and found that its expression did indeed exclusively reduce the expression of the oncogenic TEL-PDGFbetaR by 90%. While this alone was not sufficient to kill the cancer cells, this treatment enhanced the ability of imatinib to kill these cancer cells. Further, when they tested this strategy with imatinib-resistant cells, the inhibitory RNA was still able to reduce this gene's expression, and enhanced the activity of another small molecule inhibitor. This study demonstrates that small inhibitory RNA treatment may be an extremely useful adjunct to cancer treatments, and can also aid in overcoming the common problem of drug resistance when used in conjunction with anticancer agents.


'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Jun-2004


Page: 1

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
4. Small trial shows daclizumab add-on therapy improves MS outcome
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/27/2019)... Fla. (PRWEB) , ... October 26, 2019 , ... Since ... their unique reseller program. By prioritizing the success of their clients, they’ve earned a ... years in a row, and they’ve won many additional awards and accolades along the ...
(Date:10/26/2019)... ... October 24, 2019 , ... ... manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today ... at the forthcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 at ...
(Date:10/22/2019)... ... ... Join QPS experts Dawn Moore, Director of Preclinical Business Development ... on Thursday, October 31, 2019 at 11am EDT (3pm GMT/UK) to find out what ... expertise in method development, which can be evaluated through incurred sample reanalysis. Incurred sample ...
Breaking Biology News(10 mins):
(Date:10/29/2019)... ... October 29, 2019 , ... Researchers at Sony recently ... CMS-C multispectral imagers , researchers identified people by the image of a small ... imaging, face recognition, fingerprints and vasculature. , The new CMS4 series of ...
(Date:10/22/2019)... ... October 22, 2019 , ... ... announced that its lead program, DBI-001, met its primary safety endpoints, with no ... phase 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). ...
(Date:10/10/2019)... Md. (PRWEB) , ... October 09, 2019 , ... ... October 10th, groups of Montgomery County middle school and high school students have ... handle stressors, utilize relaxation techniques and physical fitness, and apply lifelong social/interpersonal, leadership, ...
(Date:10/8/2019)... ... 2019 , ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces ... company’s precursor patent, approved in the U.S. in 2017, the new patent covers the ... now markets the technology in the U.S. as the AlphaSTEM Test™. The new ...
Breaking Biology Technology:
Cached News: